Mazel Sidney 4
4 · MEDIMMUNE INC /DE · Filed Jun 19, 2007
Insider Transaction Report
Form 4
Mazel Sidney
SVP, Product Planning
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-06-18−50,000→ 0 totalExercise: $31.25Exp: 2017-02-14→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-06-18−60,000→ 0 totalExercise: $29.60Exp: 2016-06-11→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]This option, which provided for vesting with respect to 1/4 of the shares on 06/12/2007 and with respect to the remaining shares in equal quarterly installments thereafter, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $28.40 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F2]This option, which provided for vesting in equal quarterly installments beginning 5/15/2007, was cancelled in the merger in exchange for a cash payment of $26.75 per share, representing the difference between the exercise price of the option and $58.00 per share.